The Second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650000, China
NCT Number: NCT07706699
This single-center prospective randomized interventional study evaluated whether intraoperative low-current stimulation could assist recurrent laryngeal nerve localization and reduce temporary recurrent laryngeal nerve injury during thyroid surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kunming, Yunnan, 650000, China
A total of 150 patients undergoing thyroid surgery at the Second Affiliated Hospital of Kunming Medical University were randomly allocated in a 1:1:1 ratio to conventional anatomical identification, 3 mA low-current stimulation, or 5 mA low-current stimulation. All participants underwent preoperative and postoperative electronic laryngoscopy. The primary outcome was temporary recurrent laryngeal nerve injury. Secondary outcomes included permanent recurrent laryngeal nerve injury, operative duration, intraoperative blood loss, postoperative hospital stay, and stimulation-related adverse events.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Low-current stimulation at 3 mA was used as an adjunct to anatomical recurrent laryngeal nerve identification. Response was judged according to visible or palpable laryngeal twitch.
Low-current stimulation at 5 mA was used as an adjunct to anatomical recurrent laryngeal nerve identification. Response was judged according to visible or palpable laryngeal twitch.
Time frame: 6 months after surgery
Permanent recurrent laryngeal nerve injury is defined as unilateral or bilateral vocal cord paresis or paralysis detected after surgery and still present at the 6-month postoperative assessment, as confirmed by electronic laryngoscopy. The number of participants meeting this definition will be reported.
Time frame: 6 months after surgery
Permanent recurrent laryngeal nerve injury is defined as unilateral or bilateral vocal cord paresis or paralysis detected after surgery and still present at the 6-month postoperative assessment, as confirmed by electronic laryngoscopy. The number of participants meeting this definition will be reported.
Time frame: Intraoperative period
Total operative duration will be measured in minutes from the initial skin incision to completion of skin closure.
Time frame: Intraoperative period
Estimated intraoperative blood loss measured in milliliters.
Time frame: From the date of surgery until hospital discharge, assessed up to 30 days after surgery
Postoperative hospital stay will be calculated as the number of calendar days from the date of surgery to the date of hospital discharge.
Time frame: From initiation of intraoperative nerve stimulation through 30 days after surgery
The number of participants experiencing at least one stimulation-related adverse event will be reported. Stimulation-related adverse events include suspected thermal injury, arrhythmia, hemodynamic instability, muscle burn, overstimulation, or suspected false-negative nerve localization, as documented in the intraoperative and postoperative medical records.
The Second Affiliated Hospital of Kunming Medical University
Other
Clinical Utility of Low-Current Stimulation for Recurrent Laryngeal Nerve Protection During Thyroid Surgery: A Single-Center Prospective Randomized Interventional Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07710365
Endocrine System Diseases, Thyroid Disease
Gdansk, Poland
View Trial DetailsNCT06054178
Adenolymphoma, Endocrine System Diseases
Palo Alto, California, United States
View Trial DetailsNCT05579782
Endocrine Gland Neoplasms, Endocrine System Diseases
Milwaukee, Wisconsin, United States
View Trial DetailsNCT06550154
Anxiety Disorders, Behavior
L'Hospitalet de Llobregat, Barcelona, Spain
View Trial Details